Vialwirebiotech, curated
September 30, 2026, 2:46 PM
September 28, 2026
- 12:11 PM · BioPharma Dive12:11 PMKodiak skyrockets on positive study data for 2 eye drugs — BioPharma Dive
- 12:00 PM · BioWorld12:00 PMAbbvie’s Juvmo FDA approval brings new Parkinson’s option — BioWorld
- 12:00 PM · BioWorld12:00 PMSofinnova closes fourth fund for early stage med tech at €82M — BioWorld
- 12:00 PM · BioWorld12:00 PMMirum wins Atebrioz nod in FOP and reports positive HDV trial — BioWorld
- 11:52 AM · BioPharma Dive11:52 AMAn ‘off-the-shelf’ CAR-T therapy from Adicet shows promise against lupus — BioPharma Dive
- 9:00 AM · BioWorld9:00 AMJapan AMED grant supports Sola’s SOL-257 for ALS — BioWorld
- 9:00 AM · BioWorld9:00 AMFDA approves IND for Nutshell’s NRF2 degrader NTS-231 — BioWorld
- 8:52 AM · BioPharma Dive8:52 AMMerck, Daiichi end plans to seek speedy approval of lung cancer ADC — BioPharma Dive
- 8:50 AM · PharmaVoice8:50 AMWhat Bavarian Nordic’s next CEO is up against — PharmaVoice
- 4:00 AM · Drug Discovery World4:00 AMSkylark Bio expands gene therapy pipeline into CNS — Drug Discovery World
- 12:00 AM · SCMP — Tech12:00 AMChina lights up ‘super microscope’ hopes with world-leading electron gun beam — SCMP — Tech
September 27, 2026
- 2:58 AM · SCMP — Tech2:58 AMHong Kong tech chief sets June deadline for Hetao cross-border talent flow — SCMP — Tech